Pharmaceutical Compositions Of Pemetrexed

Patent No. EP2854768 (titled "Pharmaceutical Compositions Of Pemetrexed") was filed by Fresenius Kabi Oncology on May 30, 2013. The application was issued on Jun 18, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
COOKEDec 22, 2017ELKINGTON AND FIFE
GENERICS UKDec 22, 2017FRKELLY
LARSEN & BIRKEHOLMNov 3, 2017LARSEN & BIRKEHOLM

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2854768

FRESENIUS KABI ONCOLOGY
Application Number
EP13730070A
Filing Date
May 30, 2013
Status
Patent Maintained As Amended
May 16, 2025
Publication Date
Jun 18, 2025